BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30066876)

  • 1. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
    Li N; Wang C; Zhang P; You S
    Mol Med Rep; 2018 Sep; 18(3):3366-3374. PubMed ID: 30066876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs.
    Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF
    Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
    Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
    Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PPM1H on malignant phenotype of human pancreatic cancer cells.
    Zhu H; Qin H; Li DM; Liu J; Zhao Q
    Oncol Rep; 2016 Nov; 36(5):2926-2934. PubMed ID: 27599670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
    Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y
    Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study on anti-metastasis effect of emodin on human pancreatic cancer].
    Liu A; Sha L; Shen Y; Huang L; Tang X; Lin S
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(22):3167-71. PubMed ID: 22375400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent.
    Fu J; Shrivastava A; Shrivastava SK; Srivastava RK; Shankar S
    Int J Oncol; 2019 Apr; 54(4):1306-1316. PubMed ID: 30720134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
    Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
    Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
    Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
    Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z; Che X; Yang N; Bai Z; Wu Y; Zhao L; Pei H
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis.
    Li W; Sun L; Lei J; Wu Z; Ma Q; Wang Z
    Oncol Rep; 2020 Jul; 44(1):382-392. PubMed ID: 32377752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative and antimetastatic effects of emodin on human pancreatic cancer.
    Liu A; Chen H; Wei W; Ye S; Liao W; Gong J; Jiang Z; Wang L; Lin S
    Oncol Rep; 2011 Jul; 26(1):81-9. PubMed ID: 21491088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA‑1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1.
    Gong J; Wang ZX; Liu ZY
    Mol Med Rep; 2017 Jul; 16(1):143-150. PubMed ID: 28535003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.